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Objective. To test the effectiveness of adding a narrative leaflet to the current information material delivered by the NHS English
colorectal cancer (CRC) screening programme on reducing socioeconomic inequalities in uptake. Participants. 150,417 adults (59–
74 years) routinely invited to complete the guaiac Faecal Occult Blood test (gFOBt) in March 2013. Design. A cluster randomised
controlled trial (ISRCTN74121020) to compare uptake between two arms. The control arm received the standard NHS CRC
screening information material (SI) and the intervention arm received the standard information plus a supplementary narrative
leaflet, which had previously been shown to increase screening intentions (SI + N). Between group comparisons were made for
uptake overall and across socioeconomic status (SES). Results. Uptake was 57.7% and did not differ significantly between the two
trial arms (SI: 58.5%; SI + N: 56.7%; odds ratio = 0.93; 95% confidence interval: 0.81–1.06; 𝑝 = 0.27). There was no interaction
between group and SES quintile (𝑝 = 0.44). Conclusions. Adding a narrative leaflet to existing information materials does not
reduce the SES gradient in uptake. Despite the benefits of using a pragmatic trial design, the need to add to, rather than replace,
existing information may have limited the true value of an evidence-based intervention on behaviour.
We dedicate this paper in memory of Professor Jane Wardle (1950–2015)
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1. Introduction
The English Bowel (colorectal cancer, CRC) Screening Pro-
gramme involves sending a guaiac Faecal Occult Blood test
(gFOBt) to the homes of men and women aged 60–74 every
two years. It is now widely accepted that gFOBt screening
reduces cancer-specific mortality [1–3], but uptake of only
54% greatly undermines the potential public health benefits
of the programme [4]. Importantly, there are also inequalities
in screening uptake by socioeconomic status (SES) which are
likely to exacerbate existing inequalities in CRC outcomes.
Recently, there has been interest in the extent to which
socioeconomic inequalities are modified or maintained by
the information sent with invitation materials. Health com-
munication is often didactic (factsheets, charts, etc.), target-
ing a more “rational” thinking process. However, this presen-
tation may contradict preexisting beliefs and behaviours and
subsequently elicit defensive processing, such as counterar-
guing or disengagement, allowing the individual to preserve
their positive self-image, while undermining the effectiveness
of the health message [5, 6].
Narrative information is thought to target amore “heuris-
tic/affective” thinking process and, therefore, may be consid-
ered a less direct confrontation of a person’s health beliefs,
thereby reducing initial defensive processing [7, 8]. By addi-
tionally promoting mental imagery and providing role mod-
els of desired behaviours, narratives are thought to be more
engaging [7, 9].
In a recent qualitative study exploring people’s responses
to narrative information about colorectal cancer screening
information, respondents described narrative information as
helpful, making the information more vivid, relevant, and
subsequently reassuring [10]. Several US-based studies have
found narrative information to be associated with stronger
intention to take part in cancer screening than nonnarrative
information (e.g., [11, 12]), and there is some evidence of
higher uptake of cancer screening tests, particularly among
more socioeconomically deprived and ethnically diverse
groups [13, 14]. However, there is currently no researchwithin
the UKCRC screening programme exploring the potential of
narrative information on reducing the socioeconomic gradi-
ent in uptake of the English CRC screening programme.
We developed a narrative leaflet, containing quotes and
stories of theCRC screening experience fromprevious partic-
ipants, as part of a wider project to test four separate, theoret-
ically driven interventions to reduce socioeconomic inequal-
ities in CRC screening uptake [15]. The other interventions
included a “gist” based leaflet, which simplified the informa-
tion contained in the standard informationmaterials in a for-
mat suitable for thosewith low literacy skills; both the gist and
narrative leaflets were designed as a supplement to the stan-
dard information provided to patients. In addition, amend-
ments to the standard information materials were made for
two further interventions: a GP endorsed invitation letter
[16] and an enhanced reminder letter. The impact of each of
the four interventions on CRC screening uptake overall and
across socioeconomic status (SES) groups is published else-
where [15]. In this paper we describe inmore detail the results
of the narrative leaflet specifically, considering its influence
on uptake by various population characteristics (e.g., age,
gender) and if this changes across SES.
In the initial evaluation of the leaflet, we conducted a
questionnaire study with over 1200 individuals approaching
the age of screening and observed that adding the narrative
leaflet to standard screening information enhanced intention
to screen, particularly by strengthening anticipated peace
of mind from screening, enhancing feelings of vulnerability
to colorectal cancer without screening, reducing perceived
disgust with the screening procedure, and strengthening the
belief that screening can reduce the chance of dying from
the disease [17]. Here, we report the results of a national
randomised controlled trial to test the effectiveness of this
supplementary narrative leaflet on reducing socioeconomic
inequalities in uptake of the CRC screening programme.
2. Methods
A two-arm cluster randomised controlled trial
(ISRCTN74121020) based on the day of the week that
materials were mailed compared uptake between those who
were sent the standard NHS CRC screening information
material (SI) and those who were sent the standard material
plus the narrative-based information leaflet (SI + N). Ethical
approval for this study was awarded by the National Research
Ethics Service Committee London-Harrow in September
2012 (REC ref: 12/LO/1396) and an Independent Data
Monitoring & Ethics Committee (IDMEC) monitored the
progress of the trial.
2.1. Settings and Participants. In England, the CRC screening
programme invites men and women who are registered with
a GP to complete a gFOBt every two years from the age of
60 (up to 74 years). The programme is coordinated through
5 hubs (Midlands and NorthWest, Southern, London, North
East, and Eastern), where each mails screening invitations to
approximately 60,000 eligible people per month (prevalent
and incident screening rounds combined; “prevalent” relates
to individuals who are being invited for the first time or have
not accepted previous invitations to take part in the CRC
screening programme and “incident” relates to individuals
who have participated in screening at least once before).
The invitation letter is mailed with an information booklet
(“Bowel Cancer Screening: the Facts”; online version is
available at http://www.cancerscreening.nhs.uk/bowel/pub-
lications/information-leaflets.html) (standard information
SI). The gFOBt test kit and instruction leaflet is mailed 8–10
days later (see Figure 1).
Completing the gFOBt involves taking two small samples
from three separate bowel motions over a 10-day period.
The CRC screening programme in England does not impose
any dietary restrictions for completion of the test [18]. The
samples are collected using provided cardboard sticks and
applied to a specific section of guaiac paper on the test kit.The
test kit is then mailed in a hygienic, prepaid envelope back to
the hub for processing. Within 2 weeks, result letters are sent
by the hub to the individual and their General Practitioner
(GP). For those with a “normal” result, no further action is
taken and they are invited to participate again 2 years later. If
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Figure 1: Organisation and schedule of the national trial.
the returned test kit was “spoiled,” had a technical fail, or
produced an unclear result, a second test kit is sent for com-
pletion.Those with an abnormal test result are sent an invita-
tion to attend a follow-up test (i.e., colonoscopy) at their local
screening centre.
A reminder letter is sent if a completed kit is not returned
within 4 weeks. If there is no return within a further 13 weeks,
the “screening episode” is closed for that round of screening.
Thenext roundof the screening invitation process starts again
2 years later (up to the age of 74).
This study was integrated into the usual running of
each hub over a 10-day period (March 4–15, 2013). For two
hubs, the printing and distribution of invitation material is
conducted in-house through a systemoperated byHealth and
Social Care Information Centre (HSCIC). For the remaining
three hubs, this activity is contracted out to REAL Digital
International, Croydon,UK (RDI). BothCfHandRDI agreed
to accommodate the inclusion of an additional leaflet as per
study design.
2.2. Intervention
2.2.1. Control Group: Standard Information (SI) Booklet. As
per the CRC screening programme protocol, each personwas
mailed an NHS envelope containing a one-page invitation
letter and “The Facts” booklet. Approximately one week later
they were mailed a gFOBt kit with a standard instructions
leaflet. If no response was received within 4 weeks, a standard
reminder letter was sent.
2.2.2. Intervention Group: Standard Information Booklet +
Narrative Leaflet (SI + N). The initial NHS envelope con-
tained, in addition to the invitation letter and “The Facts”
booklet, an additional narrative leaflet (see Supplementary
Appendix 1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/3670150). Twenty individuals
who had previously taken part in the NHS BCSP (17 had
received “abnormal” gFOBt results, with 8 diagnosed with
CRC) were interviewed about their CRC screening expe-
rience. Key content for the leaflet was sourced from the
interview transcripts. Photographs of the interviewees were
presented alongside selected quotes (e.g., “My first thought
about the test kit was that it was going to be messy, but it didn’t
actually turn out to be.”) and individual summarised “stories.”
Two focus groups with members of a local community centre
provided feedback on an early version of the leaflet. A subse-
quent amended version was then sent to the interviewees for
review: no further changes were made. An evaluation of the
leaflet using the Comprehensibility Assessment of Materials
(SAM+CAM) questionnaire confirmed that the design, con-
tent, and layout of the final draftwere of a “superior standard”
[19]. In addition, a Flesch Reading Ease score of 66.2 was
calculated for the text within the leaflet, suggesting it was of a
“standard” reading level, easily understood by 13–15 year olds
(American grade 9) [20, 21].The final leaflet was presented in
an A4 trifold format and was entitled “Bowel Cancer Screen-
ing: People’s Stories.” For further details on leaflet develop-
ment and evaluation see McGregor et al. 2015 [17].
2.3. Randomisation. The randomisation schedule was pro-
vided to CfH, RDI, and each corresponding hub in advance
of the study commencing. Each schedule was derived from a
random number generator, whereby 10 numbers correspond-
ing to the 10-day study period were generated. Days assigned
numbers 1–5 and 6–10 were designated either control (SI) or
intervention days (SI + N).
The hubs, CfH, and RDI could not be blind to group
allocation, but a lack of direct contact with participantsmeant
that any associated bias was minimised. Participants were
unaware of their involvement in a randomised study and
therefore blind to group allocation (unless they communi-
cated with an eligible person assigned to the other group
during this study).
2.4. Outcome Measures
Primary Outcome. The primary outcome was the number of
people “adequately screened” within each group (SI versus
SI + N). To be classified as “adequately screened,” an indi-
vidual must have completed and returned a gFOBt kit within
18 weeks of being sent the invitation letter (see Figure 1), with
a definitive “normal” (no further investigation required) or
“abnormal” (requiring referral for further investigation, usu-
ally colonoscopy) screening test result at the time of data
extraction.
The Index of Multiple Deprivation (IMD) scores of
each address was the basis for estimating deprivation. IMD
assesses deprivation at the small area level (i.e., lower layer
superoutput areas (LSOA) covering about 1500 people) and
takes into account seven deprivation domains: income,
employment, health and disability, education, skills and train-
ing barriers to housing and services, crime, and living envi-
ronment. Each domain is scored separately and they are com-
bined to produce an IMD score for each LSOA. Postcodes are
linked to LSOAs and therefore to IMD scores. IMD scores
have been shown to be correlated with individual markers of
4 Gastroenterology Research and Practice
SES [22]. Within this study, national data for IMD quintiles
were applied to the obtained scores, with postcodes falling in
the first quintile denoting themost socially advantaged group
(higher SES) and those in the fifth quintile the most socially
disadvantaged group (lower SES).
The effect of screening round was investigated with
individuals classified as either prevalent first time invitees,
prevalent previous nonresponders, or incident episodes (par-
ticipated at least once previously). Age, gender, and hub were
additionally considered potential moderators. An additional
outcome was the time taken to return a completed gFOBt kit.
2.5. Statistical Considerations. The target sample size was
based on achieving a reduction in the SES gradient associated
with screening uptake. We assumed a fixed proportional
effect in each hub and estimated an average increase of 3 per-
centage points, based on increasing uptake by 5 percentage
points in the lowest (fifth) IMD quintile (most socially disad-
vantaged group) and 1 percentage point in the highest (first)
quintile, giving an overall 1-2-3-4-5 percentage point differ-
ence by quintile using themethod of Brentnall and colleagues
[23]. This estimate was drawn from the outcomes that were
considered feasible in research aiming to increase screening
uptake [24].
The final calculation assumed the composition of the hub
that required the largest sample (North West) to ensure a
sufficiently large number of people. Because the study ran-
domised by day and there is variation in the number of invita-
tions sent per day, an inflation factor of 1.7 was included.With
90% power and 5% statistical significance, 46,000 individuals
(23,000 per arm) were required to detect a 1-2-3-4-5 percent-
age point difference in uptake in the least to most deprived
IMD quintile, respectively. Due to the volume of invitations
sent out by each hub during aworkingweek (70,000–80,000),
this sample would have been achieved within only 5 days,
but such small number of clusters would have a high risk of
bias. The intervention therefore ran for 10 days, providing a
sample of approximately 140,000–160,000, to achieve enough
clusters to avoid bias [25].
The primary outcome was analysed by logistic regression
in a univariablemodel and then amultivariablemodel adjust-
ing for age, gender, hub and screening round. 𝑝 values and
95% confidence intervals calculated using conservative vari-
ance estimation to allow for the potential clustering effects in
randomisation [26]. The association between the proportion
of people adequately screened and SES was assessed by
including an interaction term between trial arm and IMD
quintile in models. The association was also investigated by
stratifying according to age, gender, screening round, and
hub. Analysis was performed on an intention-to-treat basis,
using SAS v9.3 (SAS Institute Inc., Cary, NC, USA) and Stata
v12.1 (StataCorp LP, College Station, TX, USA).
HSCIC organised for the relevant pseudoanonymised
data to be extracted from the Bowel Cancer Screening System
and transferred to one coordinating hub (Southern). At this
hub, the data were cleaned and further anonymised before
being securely transferred to the research team for analysis.
SI: standard information
Allocated to SI group 
Randomised
Adequately screened Adequately screened
Missing IMD data (n = 272)
(n = 73,722)
(n = 41,822)(n = 44,904)
(n = 150,417)
Missing IMD data (n = 274)
(n = 76,695)
SI+N: standard information plus narrative leaflet
Allocated to SI+N
Figure 2: Flowchart of participation.
2.6. Assessment of Concurrent Initiatives. An audit of current
and imminent bowel cancer screening research and health
promotion activities within England was carried out and reg-
ularly updated throughout the course of this research study.
This audit served to highlight any possible confounding fac-
tors to consider in our analysis and involved regular contact
with key informants including Quality Assurance Reference
Centre (QARC) directors, Specialist Screening Practition-
ers (SSPs), BCSP managers, and representatives from the
National Awareness and Early Diagnosis Initiative (NAEDI),
Cancer Research Network, and Strategic Clinical Network.
3. Results
Between March 4 and 15, 2013, 150,417 individuals were
allocated to either the control group (SI: 76,695) or the inter-
vention group (SI + N: 73,722) (see Figure 2). Baseline char-
acteristics were generally well-balanced, although there was
a higher proportion of incident screens in the control group,
and randomisation resulted in two hubs (Southern and East-
ern) having a disproportionate number of people in each trial
arm (Table 1).
The median time (range) to return a kit was 26 days (10–
126) and 26 days (11–126) for the SI and SI +N groups, respec-
tively. Spoilt kits were returned by only 1,204 individuals (SI:
595; SI + N: 609). Overall, more than half (57.7%; 86,726) of
those invited returned a gFOBt kit within 18 weeks of their
invitation that led to a “definitive” screening test result of
either “normal” or “abnormal” within the timeframe of the
study (i.e., were “adequately screened”).
The intervention arm (SI + N = 56.7%; 41,822) had a
proportion of adequately screened individuals 1.8 percentage
points lower than the control arm (SI = 58.5%; 44,904); this
reduction was not statistically significant (unadjusted odds
ratio (OR) = 0.93, 95% confidence interval (CI) 0.81–1.06,
𝑝 = 0.27; adjusted OR = 1.00, 95% CI 0.96–1.03, 𝑝 = 0.80).
For each trial arm, the proportion of adequately screened
individuals within each IMDquintile decreased as the level of
deprivation increased (SI: 66.8% to 46.0%; SI + N: 64.6% to
42.4%; Table 2). There was no evidence of a reduction in the
social gradient in the intervention arm (interaction between
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Table 1: Baseline characteristics.
SI SI + N
𝑁 = 76, 695 𝑁 = 73,722
Median (range) Median (range)
Age at invitation (in years) 65.0 (59.0–74.0) 65.0 (59.0–74.0)
IMD deprivation score 15.1 (0.5–87.8) 15.1 (0.5–87.8)
% (𝑛) % (𝑛)
Gender
Female 51.0 (39,086) 51.5 (37,937)
Male 49.0 (37,609) 48.5 (35,785)
IMD quintile
1st quintile (0–8.49, least deprived) 22.3 (17,073) 23.2 (17,027)
2nd quintile (8.50–13.79) 23.1 (17,675) 22.5 (16,517)
3rd quintile (13.80–21.35) 21.1 (16,161) 20.8 (15,287)
4th quintile (21.36–34.17) 17.5 (13,385) 17.6 (12,897)
5th quintile (34.18–87.80, most deprived) 15.9 (12,127) 16.0 (11,722)
Missing 274 272
Hub
Midlands and North West 27.5 (21,118) 29.1 (21,421)
Southern 21.8 (16,723) 28.0 (20,667)
London 11.5 (8,795) 11.5 (8,509)
North East 16.8 (12,900) 17.7 (13,053)
Eastern 22.4 (17,159) 13.7 (10,072)
Screening round
Prevalent first time invitees 16.3 (12,510) 20.7 (15,281)
Prevalent previous nonresponders 29.8 (22,892) 30.1 (22,209)
Incident episodes 53.8 (41,293) 49.1 (36,232)
SI: standard information; SI + N: standard information plus narrative leaflet; IMD: index of multiple deprivation.
the trial intervention and deprivation quintile: unadjusted
𝑝 = 0.44, adjusted 𝑝 = 0.11); however, a lower proportion
of individuals were adequately screened in the intervention
arm than the control arm within the most deprived quintile
(unadjusted OR = 0.86, 95% CI 0.74–1.00, 𝑝 = 0.05; adjusted
OR = 0.92, 95% CI 0.86–0.98, 𝑝 = 0.02).
There was no difference in the overall proportion of
individuals adequately screened between the trial groups by
age at invitation (median age = 65 yrs; Table 3). The pro-
portion screened was generally lower in younger individuals
and decreased with deprivation in both arms. There was no
evidence of an association between the trial arm and depri-
vation quintile on the proportion screened in either age group
(unadjusted interaction: <65 yrs, 𝑝 = 0.37; ≥65 yrs, 𝑝 = 0.67;
adjusted interaction: <65 yrs, 𝑝 = 0.07; ≥65 yrs, 𝑝 = 0.88).
There was no difference in the overall proportion ade-
quately screened between the trial arms by gender (Table 4).
The proportion screened was generally lower in men and
decreased with deprivation in both arms, but with no arm-
by-deprivation quintile interaction for men (unadjusted 𝑝 =
0.33; adjusted 𝑝 = 0.05) or women (unadjusted 𝑝 = 0.68;
adjusted 𝑝 = 0.60).
The proportion adequately screened was lower in people
who had not previously taken part in CRC screening and
decreased with deprivation in both arms (Table 5), but there
was no evidence of an association between trial arm and
deprivation quintile in either screening round (unadjusted
interaction: prevalent first-time invitees, 𝑝 = 0.30; prevalent
previous nonresponders, 𝑝 = 0.59; incident episodes, 𝑝 =
0.70) (adjusted interaction: prevalent first-time invitees, 𝑝 =
0.30; prevalent previous nonresponders, 𝑝 = 0.71; incident
episodes, 𝑝 = 0.60).
There was no difference in the overall proportion of
individuals adequately screened between the trial groups in
each hub (Table 6).Therewas no interactionwith deprivation
score in any of the hubs (unadjusted interaction: Midlands
and North West, 𝑝 = 0.93; Southern, 𝑝 = 0.68; London,
𝑝 = 0.84; North East, 𝑝 = 0.24; Eastern, 𝑝 = 0.69) (adjusted
interaction: Midlands and North West, 𝑝 = 0.61; Southern,
𝑝 = 0.60; London, 𝑝 = 0.09; North East, 𝑝 = 0.13; Eastern,
𝑝 = 0.51).
As part of the concurrent initiative survey, we received
details of 62 local health promotion activities and 17 research
projects being undertaken at the same time as this trial. None
of these initiatives were limited to occurring on the same days
the narrative leaflet was sent out.
4. Discussion
This study assessed the impact of the addition of a narrative-
based leaflet to existing information on inequalities in uptake
of CRC screening in England. The leaflet was designed to
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Table 2: Proportion of individuals invitedwhowere adequately screened†, according to gender, age, IMDquintile‡, hub, and screening round.
SI SI + N Adjusted odds ratio
𝑝 value
% (𝑛) % (𝑛) (95% CI)
Total 58.5 (44,904) 56.7 (41,822) 1.00 (0.96–1.03) 0.80
Gender
Female 60.9 (23,811) 59.3 (22,499) 1.01 (0.96–1.05) 0.77
Male 56.1 (21,093) 54.0 (19,323) 0.98 (0.94–1.03) 0.50
Age (median split)
<65 years 55.2 (19,014) 53.3 (18,264) 1.01 (0.97–1.05) 0.67
≥65 years 61.2 (25,890) 59.7 (23,558) 0.98 (0.92–1.04) 0.45
IMD quintile
1st quintile (0–8.49, least deprived) 66.8 (11,411) 64.6 (11,005) 0.98 (0.93–1.04) 0.57
2nd quintile (8.50–13.79) 62.7 (11,080) 62.1 (10,253) 1.00 (0.94–1.06) 0.91
3rd quintile (13.80–21.35) 59.4 (9,601) 58.3 (8,911) 1.05 (0.97–1.13) 0.24
4th quintile (21.36–34.17) 52.9 (7,083) 50.7 (6,535) 1.00 (0.94–1.06) 0.95
5th quintile (34.18–87.80, most deprived) 46.0 (5,580) 42.4 (4,966) 0.92 (0.86–0.98) 0.02
Hub
Midlands and North West 57.6 (12,163) 53.4 (11,439) 0.95 (0.88–1.03) 0.22
Southern 60.2 (10,069) 61.5 (12,712) 1.00 (0.91–1.10) 0.98
London 49.2 (4,327) 45.4 (3,864) 1.00 (0.95–1.05) 0.95
North East 60.8 (7,837) 59.1 (7,716) 0.98 (0.90–1.06) 0.56
Eastern 61.2 (10,508) 60.5 (6,091) 1.07 (0.99–1.16) 0.08
Screening round
Prevalent first time invitees 49.8 (6,231) 50.2 (7,678) 1.03 (0.99–1.08) 0.14
Prevalent previous nonresponders 14.3 (3,284) 14.0 (3,113) 0.97 (0.90–1.04) 0.35
Incident episodes 85.7 (35,389) 85.6 (31,031) 0.99 (0.94–1.04) 0.64
SI: standard information; SI + N: standard information plus narrative leaflet
†Returned a gFOBt kit (or kits) within 18 weeks of being sent the invitation, with a definitive “normal” (no further investigation required) or “abnormal”
(requiring referral for further investigation, usually colonoscopy) screening test result available at the time of data extraction.
‡546 (274 SI and 272 SI + N) individuals missing an IMD score, 301 of these were adequately screened (149 SI and 152 SI + N).
Table 3: Proportion of individuals who were adequately screened†, according to IMD quintile‡ and median age at invitation.
Age at invitation <65 years Age at invitation ≥65 years
SI SI + N SI SI + N
𝑁 = 34,415 𝑁 = 34,260 𝑁 = 42,280 𝑁 = 39,462
% (𝑛) % (𝑛) % (𝑛) % (𝑛)
Adequately screened 55.2 (19,014) 53.3 (18,264) 61.2 (25,890) 59.7 (23,558)
1st quintile (least deprived) 64.4 (4,801) 61.4 (4,639) 68.7 (6,610) 67.2 (6,366)
2nd quintile 59.3 (4,577) 59.6 (4,424) 65.3 (6,503) 64.1 (5,829)
3rd quintile 55.6 (4,045) 55.1 (3,907) 62.5 (5,556) 61.0 (5,004)
4th quintile 49.4 (3,043) 47.1 (2,955) 55.9 (4,040) 54.1 (3,580)
5th quintile (most deprived) 43.5 (2,471) 39.3 (2,267) 48.3 (3,109) 45.4 (2,699)
SI: standard information; SI + N: standard information plus narrative leaflet.
†Returned a gFOBt kit (or kits) within 18 weeks of being sent the invitation, with a definitive “normal” (no further investigation required) or “abnormal”
(requiring referral for further investigation, usually colonoscopy) screening test result available at the time of data extraction.
‡546 (274 SI and 272 SI + N) individuals missing an IMD score, 301 of these were adequately screened (149 SI and 152 SI + N).
reduce barriers to uptake but it neither increased the overall
number of people returning a completed gFOBt kit nor
decreased the associated SES gradient. In fact, this study
appeared to produce negative results at various points. How-
ever, we found that this was due to the imbalance in screening
round, with a higher proportion of incident screens in
the control group; this is because ∼85% of incident screens
were adequately screened, compared to only ∼50% of preva-
lent first-time invitees and ∼14% of prevalent previous non-
responders. After adjusting for baseline characteristics, we
found no evidence of an overall effect in either direction
(OR = 1.00, 95% CI 0.96–1.03, 𝑝 = 0.80) nor a general trend
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Table 4: Proportion of individuals who were adequately screened†, according to IMD quintile‡ and gender.
Males Females
SI SI + N SI SI + N
𝑁 = 37,609 𝑁 = 35,785 𝑁 = 39,086 𝑁 = 37,937
% (𝑛) % (𝑛) % (𝑛) % (𝑛)
Adequately screened 56.1 (21,093) 54.0 (19,323) 60.9 (23,811) 59.3 (22,499)
1st quintile (least deprived) 63.9 (5,342) 61.2 (5,014) 69.7 (6,069) 67.8 (5,991)
2nd quintile 59.8 (5,186) 59.6 (4,757) 65.5 (5,894) 64.4 (5,496)
3rd quintile 56.7 (4,460) 55.6 (4,055) 61.9 (5,141) 60.7 (4,856)
4th quintile 50.8 (3,353) 48.1 (3,029) 55.0 (3,730) 53.1 (3,506)
5th quintile (most deprived) 44.7 (2,676) 40.7 (2,394) 47.3 (2,904) 44.1 (2,572)
SI: standard information; SI + N: standard information plus narrative leaflet.
†Returned a gFOBt kit (or kits) within 18 weeks of being sent the invitation, with a definitive “normal” (no further investigation required) or “abnormal”
(requiring referral for further investigation, usually colonoscopy) screening test result available at the time of data extraction.
‡546 (274 SI and 272 SI + N) individuals missing an IMD score, 301 of these were adequately screened (149 SI and 152 SI + N).
Table 5: Proportion of individuals who were adequately screened†, according to IMD quintile‡ and screening round.
Prevalent first time invitees Prevalent previous nonresponders Incident episodes
SI SI + N SI SI + N SI SI + N
𝑁 = 12,510 𝑁 = 15,281 𝑁 = 22,892 𝑁 = 22,209 𝑁 = 41293 𝑁 = 36232
% (𝑛) % (𝑛) % (𝑛) % (𝑛) % (𝑛) % (𝑛)
Adequately screened 49.8 (6,231) 50.2 (7,678) 14.3 (3,284) 14.0 (3,113) 85.7 (35,389) 85.6 (31,031)
1st quintile (least deprived) 58.0 (1,585) 58.9 (1,953) 17.8 (705) 16.3 (685) 87.9 (9,121) 88.0 (8,367)
2nd quintile 54.5 (1,494) 55.9 (1,827) 16.1 (775) 16.3 (705) 87.2 (8,811) 86.7 (7,721)
3rd quintile 50.5 (1,312) 51.4 (1,601) 14.2 (665) 15.7 (709) 85.7 (7,624) 86.1 (6,601)
4th quintile 44.7 (1,011) 44.4 (1,282) 13.1 (598) 12.5 (552) 83.7 (5,474) 84.1 (4,701)
5th quintile (most deprived) 37.9 (801) 37.3 (979) 11.1 (527) 9.6 (448) 81.0 (4,252) 79.8 (3,539)
SI: standard information; SI + N: standard information plus narrative leaflet.
†Returned a gFOBt kit (or kits) within 18 weeks of being sent the invitation, with a definitive “normal” (no further investigation required) or “abnormal”
(requiring referral for further investigation, usually colonoscopy) screening test result available at the time of data extraction.
‡546 (274 SI and 272 SI + N) individuals missing an IMD score, 301 of these were adequately screened (149 SI and 152 SI + N).
within subgroups.The narrative leaflet, therefore, had neither
a positive nor negative impact on uptake. Overall, the use of
this supplementary intervention was unsuccessful and it is
unlikely that the lack of effect can be ascribed to concurrent
initiatives.
Our study benefited from a pragmatic design, including
access to a very large sample size, with no exclusion criteria,
and the real-life applicability of the intervention within
an established CRC screening programme [27]. However,
our results run counter to previous research in the USA
which demonstrated the potential effectiveness of narrative
information to increase CRC screening uptake [13, 14]. It is
possible that, within a UK setting, narratives are considered
to be credible and useful for CRC screening decision making
[10] but are, in reality, not an effective intervention to increase
uptake. However, upon reflection, our negative results may
also have stemmed from the need to fit the intervention into
the existing screening programme structure. This require-
ment may have limited the impact of the narrative in two
ways.
Firstly, it meant that the additional information leaflet
could only be inserted at the preinvitation stage; due to logis-
tics of the packing equipment used in two hubs, inclusion of
the leaflet with the second mail out (test kit and instructions)
was not possible. Although research indicates the importance
of a preinvitation contact point at improving uptake [28],
adding a narrative leaflet addressing barriers to screening at
this stage might not have been the most appropriate time-
point. Although we have previously shown the leaflet to
increase intention to complete screening in screening na¨ıve
individuals [17], one may argue that individuals receiving
repeat invitations may not engage with the information sent
at the preinvitation stage to the same extent as those invited
for the first time. Within this study the majority of invitees
were incident screens and, therefore, simply may not have
engaged with the leaflet. Had the leaflet accompanied the test
kit, individual may have beenmore likely to attend to it and it
may have additionally acted as a point-of-choice prompt and
subsequently had a stronger impact on actual test completion
[29]. The most effective positioning of the narrative leaflet
requires further investigation.
Secondly, the narrative leaflet had to be added to, rather
than replace, existing informational literature. Despite the
brevity of the narrative leaflet, by adding it to existing infor-
mationmaterial, the total amount ofwrittenmaterial received
by the individual increased. This might have undermined
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the goal of making the screening offer more visible to lower-
literacy individuals. The impact of a “stand-alone” narrative
leaflet at different points in the invitation pathway and
in comparison to existing materials therefore needs to be
examined.
In addition, the provision of narrative information in dif-
ferent formats (e.g., web, video)which integrate oral and non-
verbal communication methods, thus allowing more narra-
tive information to be communicated, and perhaps in a more
engagingmanner, should also be tested. Previous research has
also suggested a benefit of using either a targeted or tailored
approach in health communication materials (e.g., [30, 31]).
Had multiple variations of the leaflet been developed to
specifically target, for example, those who were being invited
for the first time and previous nonresponders separately,
the results may have been more positive. However, within a
national programme, the application of targeted and tailored
materials is complex. Future research is needed to investigate
ways to implement such interventions on a national scale.
Further limitations of the study include the marker of
SES used to depict the gradient. While the Index of Multiple
Deprivation (IMD) is a comprehensivemeasure of area depri-
vation, it does not include personal circumstances and there-
fore individuals may not be as affluent or as disadvantaged
as their postcode suggests.
The current study does not support the inclusion of a nar-
rative leaflet at the preinvitation stage of the CRC Screening
Programme, but further research could be developed to elu-
cidate if narratives, in another format and/or position, could
positively impact uptake of the CRC screening programme
overall and reduce inequalities.
Specifically, there is evidence that creating additional
reminder letters is associated with increasing uptake [32, 33].
One potential advantage of using the narrative leaflet as part
of an additional reminder would be that the leaflet could be
used on its own rather than in combination with the standard
informed choice leaflet. ARCTcomparing the effectiveness of
such a reminder with the narrative versus the standard leaflet
would offer additional insights into the potential impact of
our leaflet and circumvent the aforementioned limitations.
5. Conclusion
This pragmatic cluster randomised-trial found that providing
a supplementary information leaflet, which presents a narra-
tive account of the gFOBt-based, organisedNHSCRC screen-
ing programme in England, neither increased overall uptake
nor reduced inequalities, when delivered with the standard
information material. This is despite the leaflet previously
being found to significantly increase intentions to participate
in CRC screening. The results do not support a change in
policy at this time, but future research could investigate the
impact of a stand-alone narrative leaflet at other points in the
communication pathway.
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